David M. Knott’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | $2.09M | Buy |
10,416
+864
| +9% | +$173K | 0.76% | 34 |
|
2021
Q2 | $2.44M | Buy |
9,552
+334
| +4% | +$85.4K | 0.87% | 32 |
|
2021
Q1 | $2.45M | Sell |
9,218
-617
| -6% | -$164K | 1.05% | 28 |
|
2020
Q4 | $3.63M | Buy |
9,835
+657
| +7% | +$242K | 1.64% | 15 |
|
2020
Q3 | $2.24M | Buy |
9,178
+386
| +4% | +$94.3K | 1.31% | 18 |
|
2020
Q2 | $2.53M | Hold |
8,792
| – | – | 1.38% | 17 |
|
2020
Q1 | $1.79M | Buy |
8,792
+977
| +13% | +$199K | 1.13% | 21 |
|
2019
Q4 | $3.49M | Hold |
7,815
| – | – | 1.42% | 17 |
|
2019
Q3 | $2.4M | Buy |
7,815
+583
| +8% | +$179K | 1.01% | 20 |
|
2019
Q2 | $2.3M | Buy |
7,232
+2,854
| +65% | +$908K | 0.97% | 21 |
|
2019
Q1 | $1.84M | Hold |
4,378
| – | – | 0.73% | 30 |
|
2018
Q4 | $1.33M | Buy |
4,378
+1,022
| +30% | +$311K | 0.63% | 32 |
|
2018
Q3 | $1.21M | Buy |
3,356
+297
| +10% | +$107K | 0.39% | 38 |
|
2018
Q2 | $1.12M | Buy |
3,059
+997
| +48% | +$365K | 0.42% | 38 |
|
2018
Q1 | $609K | Buy |
2,062
+1,329
| +181% | +$393K | 0.25% | 55 |
|
2017
Q4 | $307K | Buy |
733
+373
| +104% | +$156K | 0.12% | 72 |
|
2017
Q3 | $119K | Buy |
+360
| New | +$119K | 0.05% | 85 |
|